Literature DB >> 8593014

Antibacterial action of ciprofloxacin.

D J Mason1, E G Power, H Talsania, I Phillips, V A Gant.   

Abstract

The mechanisms by which quinolones rapidly kill are ill defined. We have investigated the action of ciprofloxacin on Escherichia coli KL16 with a combination of traditional and flow cytometric methods and have analyzed cells for changes in membrane potential, membrane integrity, oxidative metabolism, morphology, and viability. Log-phase cultures were exposed to various concentrations (0.1, 1, 10, and 100 times the MIC) of ciprofloxacin and analyzed at regular intervals over 120 min. We also measured protein synthesis in the related strain PQ37 cultured under the same conditions over 300 min, using a colorimetric assay for beta-galactosidase release. Despite a 3-log order decrease in CFU after 60-min exposure to 10 and 100 times the MIC of ciprofloxacin, there was no equivalent decrease in bacterial numbers as determined by both light microscopy and flow cytometry. Furthermore, while these bacteria showed concentration-dependent morphological changes, most were capable not only of excluding the fluorescent nucleic acid-binding dye propidium iodide, but also of reducing the tetrazolium dye cyanoditodyl tetrazolium chloride. Over 90% of the bacteria maintained a membrane potential [as determined by exclusion of bis-[1,3-dibutylbarbituric acid) trimethine oxonol] when exposed to ciprofloxacin for 120 min, except at 100 times the MIC, when this figure fell to < 10%. Finally, protein synthesis was either maintained or induced at all concentrations of ciprofloxacin up to 5 h postexposure. Taken together, these results demonstrate the continuing physical and metabolic survival of ciprofloxacin-exposed bacteria; we suggest parallels with the concept of the viable nonculturable state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593014      PMCID: PMC163024          DOI: 10.1128/AAC.39.12.2752

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.

Authors:  A Sugino; C L Peebles; K N Kreuzer; N R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

2.  Membrane permeability changes associated with DNA gyrase inhibitors in Escherichia coli.

Authors:  T J Dougherty; J J Saukkonen
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

3.  Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin.

Authors:  J M Diver; R Wise
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

4.  The response of Escherichia coli to ciprofloxacin and norfloxacin.

Authors:  T S Elliott; A Shelton; D Greenwood
Journal:  J Med Microbiol       Date:  1987-02       Impact factor: 2.472

5.  Nalidixic acid: an antibacterial paradox.

Authors:  G C Crumplin; J T Smith
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

6.  Viable but nonrecoverable stage of Salmonella enteritidis in aquatic systems.

Authors:  D B Roszak; D J Grimes; R R Colwell
Journal:  Can J Microbiol       Date:  1984-03       Impact factor: 2.419

7.  Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.

Authors:  M W Hane; T H Wood
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

8.  Lymphocyte membrane potential and Ca2+-sensitive potassium channels described by oxonol dye fluorescence measurements.

Authors:  H A Wilson; T M Chused
Journal:  J Cell Physiol       Date:  1985-10       Impact factor: 6.384

9.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; T Itoh; J I Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  The SOS Chromotest, a colorimetric bacterial assay for genotoxins: procedures.

Authors:  P Quillardet; M Hofnung
Journal:  Mutat Res       Date:  1985-06       Impact factor: 2.433

View more
  37 in total

1.  Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure.

Authors:  H J Wickens; R J Pinney; D J Mason; V A Gant
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Mapping an interface of SecY (PrlA) and SecE (PrlG) by using synthetic phenotypes and in vivo cross-linking.

Authors:  C R Harris; T J Silhavy
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

3.  Induction of Shiga Toxin-Encoding Prophage by Abiotic Environmental Stress in Food.

Authors:  Yuan Fang; Ryan G Mercer; Lynn M McMullen; Michael G Gänzle
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

4.  Modeling antibiotic tolerance in biofilms by accounting for nutrient limitation.

Authors:  Mark E Roberts; Philip S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

5.  Online monitoring of Escherichia coli ghost production.

Authors:  W Haidinger; M P Szostak; W Jechlinger; W Lubitz
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

6.  Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis.

Authors:  Marija Djukic; Tobias Böttcher; Andreas Wellmer; Joachim Gerber; Viola V Brocke; Helmut Eiffert; Roland Nau
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 7.  Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses.

Authors:  H M Davey; D B Kell
Journal:  Microbiol Rev       Date:  1996-12

8.  Rapid assessment of antibiotic effects on Escherichia coli by bis-(1,3-dibutylbarbituric acid) trimethine oxonol and flow cytometry.

Authors:  R I Jepras; F E Paul; S C Pearson; M J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

9.  Flow cytometric monitoring of antibiotic-induced injury in Escherichia coli using cell-impermeant fluorescent probes.

Authors:  F C Mortimer; D J Mason; V A Gant
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

10.  Moxifloxacin in the therapy of experimental pneumococcal meningitis.

Authors:  H Schmidt; A Dalhoff; K Stuertz; F Trostdorf; V Chen; O Schneider; C Kohlsdorfer; W Brück; R Nau
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.